Skip to main content
AAN.com

Abstract

Objective:

There are few detailed data on cognition in patients undergoing dialysis. We evaluated the frequency of and risk factors for poor cognitive performance using detailed neurocognitive testing.

Methods:

In this cross-sectional cohort study, 314 hemodialysis patients from 6 Boston-area hemodialysis units underwent detailed cognitive assessment. The neuropsychological battery assessed a broad range of functions, with established age-, sex-, and education-matched normative scores. Principal component analysis was used to derive composite scores for memory and executive function domains. Risk factors for each domain were evaluated using linear regression adjusting for age, sex, race, and education status. Analyses were repeated in those with Mini-Mental State Examination (MMSE) score ≥24.

Results:

Compared with population norms, patients on dialysis had significantly poorer executive function but not memory performance, a finding that persisted in the subgroup with MMSE score ≥24. In adjusted analyses, vascular risk factors and vascular disease were associated with lower executive function (p < 0.01).

Conclusions:

There is a high frequency of poor cognitive performance in hemodialysis patients, primarily affecting executive function. Risk factors for worse executive function include vascular risk factors as well as vascular disease. Normal performance on the MMSE does not preclude impaired cognitive function, because individuals with MMSE score ≥24 also have a high frequency of poor cognitive performance.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (tables_e-1_-_e-3.pdf)

STUDY FUNDING

The study was funded by the NIDDK through grants R21 DK068310 (M.J.S.), R01 DK078204 (M.J.S.), and K23 DK71636 (D.E.W.).

REFERENCES

1.
Fazekas G, Fazekas F, Schmidt R, Kapeller P, Offenbacher H, Krejs GJ. Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci 1995;134:83–88.
2.
Kutlay S, Nergizoglu G, Duman N, et al. Recognition of neurocognitive dysfunction in chronic hemodialysis patients. Ren Fail 2001;23:781–787.
3.
Sehgal AR, Grey SF, DeOreo PB, Whitehouse PJ. Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis 1997;30:41–49.
4.
Cannata AP, Alberoni M, Franceschi M, Mariani C. Frontal impairment in subcortical ischemic vascular dementia in comparison to Alzheimer's disease. Dement Geriatr Cogn Disord 2002;13:101–111.
5.
Looi JC, Sachdev PS. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology 1999;53:670–678.
6.
Roman GC. Vascular dementia: distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc 2003;51:S296–S304.
7.
Traykov L, Baudic S, Thibaudet MC, Rigaud AS, Smagghe A, Boller F. Neuropsychological deficit in early subcortical vascular dementia: comparison to Alzheimer's disease. Dement Geriatr Cogn Disord 2002;14:26–32.
8.
Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
9.
Blair J, Spreen O. Predicting premorbid IQ: a revision of the National Adult Reading Test. Clin Neuropsychologist 1989;3:129–136.
10.
Tulsky D, Zhu J, Lebetter M. Wechsler Adult Intelligence Scale-Third Edition (WAIS-III), Wechsler Memory Scale-Third Scale (WMS-III): Technical Manual. San Antonio: Harcourt Brace & Company; 1997.
11.
Heaton R, Grant I, Mathews C. Comprehensive Norms for an Expanded Halstead-Reitan Battery. Odessa: Psychological Assessment Resources Inc.; 1991.
12.
Salib E, McCarthy J. Mental Alternation Test (MAT): a rapid and valid screening tool for dementia in primary care. Int J Geriatr Psychiatry 2002;17:1157–1161.
13.
Benton A, Hamsher K. Multilingual Aphasia Examination. Iowa City: University of Iowa; 1978.
14.
Radloff LS. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas 1977;1:385–401.
15.
Sorensen EP, Sarnak MJ, Tighiouart H, et al. The kidney disease quality of life cognitive function subscale and cognitive performance in maintenance hemodialysis patients. Am J Kidney Dis 2012;60:417–426.
16.
Billick SB, Siedenburg E, Burgert W, Bruni-Solhkhah SM. Validation of the Mental Alternation Test with the Mini-Mental State Examination in geriatric psychiatric inpatients and normal controls. Compr Psychiatry 2001;42:202–205.
17.
Jones BN, Teng EL, Folstein MF, Harrison KS. A new bedside test of cognition for patients with HIV infection. Ann Intern Med 1993;119:1001–1004.
18.
Troyer AK. Normative data for clustering and switching on verbal fluency tasks. J Clin Exp Neuropsychol 2000;22:370–378.
19.
Heyer NJ, Bittner AC, Echeverria D. Analyzing multivariate neurobehavioral outcomes in occupational studies: a comparison of approaches. Neurotoxicol Teratol 1996;18:401–406.
20.
Brady CB, Gaziano JM, Cxypoliski RA, et al. Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. Am J Kidney Dis 2009;54:440–449.
21.
Kurella Tamura M, Larive B, Unruh ML, et al. Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials. Clin J Am Soc Nephrol 2011;5:1429–1438.
22.
Murray AM, Tupper DE, Knopman DS, et al. Cognitive impairment in hemodialysis patients is common. Neurology 2006;67:216–223.
23.
Pereira AA, Weiner DE, Scott T, et al. Subcortical cognitive impairment in dialysis patients. Hemodial Int 2007;11:309–314.
24.
Weiner DE, Scott TM, Giang LM, et al. Cardiovascular disease and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis 2011;58:773–781.
25.
Collins AJ, Foley RN, Herzog C, et al. Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis 2010;55:S1–A7.
26.
Schaeffner ES, Mehta J, Winkelmayer WC. Educational level as a determinant of access to and outcomes after kidney transplantation in the United States. Am J Kidney Dis 2008;51:811–818.
27.
Khattak M, Sandhu GS, Desilva R, Goldfarb-Rumyantzev AS. Association of education level with dialysis outcome. Hemodial Int 2012;16:82–88.
28.
Murray AM, Pederson SL, Tupper DE, et al. Acute variation in cognitive function in hemodialysis patients: a cohort study with repeated measures. Am J Kidney Dis 2007;50:270–278.
29.
Gallai V, Alberti A, Buoncristiani U, Firenze C, Mazzotta G. Changes in auditory P3 event-related potentials in uremic patients undergoing haemodialysis. Electromyogr Clin Neurophysiol 1994;34:397–402.
30.
Lewis EG, O'Neill WM, Dustman RE, Beck EC. Temporal effects of hemodialysis on measures of neural efficiency. Kidney Int 1980;17:357–363.
31.
Smith BC, Winslow EH. Cognitive changes in chronic renal patients during hemodialysis. ANNA J 1990;17:283–286.
32.
Tennyson TE, Brown WS, Vaziri ND, Jennison JH. Event-related potential changes during hemodialysis. Int J Artif Organs 1985;8:269–276.
33.
Williams MA, Sklar AH, Burright RG, Donovick PJ. Temporal effects of dialysis on cognitive functioning in patients with ESRD. Am J Kidney Dis 2004;43:705–711.
34.
Drew D, Tighiouart H, Scott T, et al. Cognitive performance before and during hemodialysis: a randomized crossover trial. American Society of Nephrology Annual Meeting, San Diego, 2012, Abstract PO270.

Information & Authors

Information

Published In

Neurology®
Volume 80Number 5January 29, 2013
Pages: 471-480
PubMed: 23303848

Publication History

Received: May 29, 2012
Accepted: September 17, 2012
Published online: January 9, 2013
Published in print: January 29, 2013

Permissions

Request permissions for this article.

Disclosure

The authors report no disclosures relevant to the manuscript. Go to Neurology.org for full disclosures.

Authors

Affiliations & Disclosures

Mark J. Sarnak, MD, MS
From the Division of Nephrology (M.J.S., K.V.L., E.P.S., L.M.G., D.A.D., K.S., D.E.W.), Department of Medicine, Department of Psychiatry (T.M.S.), and Biostatistics Research Center (H.T.), Tufts Medical Center, Boston; Division of Nephrology (J.A.S.), St. Elizabeth's Medical Center, Brighton; and Division of Nephrology (A.K.S.), Brigham and Women's Hospital, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
Editorial Board Annals of Internal Medicine 2010-2013
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
Data Safety monitoring board of trial of vitamin D in kidney disease
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NIH. K24, and 2 RO1 grant applications. Listed in Manuscript
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Hocine Tighiouart, MS
From the Division of Nephrology (M.J.S., K.V.L., E.P.S., L.M.G., D.A.D., K.S., D.E.W.), Department of Medicine, Department of Psychiatry (T.M.S.), and Biostatistics Research Center (H.T.), Tufts Medical Center, Boston; Division of Nephrology (J.A.S.), St. Elizabeth's Medical Center, Brighton; and Division of Nephrology (A.K.S.), Brigham and Women's Hospital, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
American Journal of Kidney Diseases, Statistical Editor, 5 years
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Tammy M. Scott, PhD
From the Division of Nephrology (M.J.S., K.V.L., E.P.S., L.M.G., D.A.D., K.S., D.E.W.), Department of Medicine, Department of Psychiatry (T.M.S.), and Biostatistics Research Center (H.T.), Tufts Medical Center, Boston; Division of Nephrology (J.A.S.), St. Elizabeth's Medical Center, Brighton; and Division of Nephrology (A.K.S.), Brigham and Women's Hospital, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NIH/NCRR, UL1 RR025752, Role: Research methodologist, Research Design and Conduct center NIH, 1 R01 DK065114-01, Role: Co-Investigator NIH, NGA-5U01-AG020480-06, Role: Co-Investigator NIH, 1R21DK070249-01, Role: Co-Investigator
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Kristina V. Lou, MS, MPH
From the Division of Nephrology (M.J.S., K.V.L., E.P.S., L.M.G., D.A.D., K.S., D.E.W.), Department of Medicine, Department of Psychiatry (T.M.S.), and Biostatistics Research Center (H.T.), Tufts Medical Center, Boston; Division of Nephrology (J.A.S.), St. Elizabeth's Medical Center, Brighton; and Division of Nephrology (A.K.S.), Brigham and Women's Hospital, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Eric P. Sorensen
From the Division of Nephrology (M.J.S., K.V.L., E.P.S., L.M.G., D.A.D., K.S., D.E.W.), Department of Medicine, Department of Psychiatry (T.M.S.), and Biostatistics Research Center (H.T.), Tufts Medical Center, Boston; Division of Nephrology (J.A.S.), St. Elizabeth's Medical Center, Brighton; and Division of Nephrology (A.K.S.), Brigham and Women's Hospital, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Lena M. Giang
From the Division of Nephrology (M.J.S., K.V.L., E.P.S., L.M.G., D.A.D., K.S., D.E.W.), Department of Medicine, Department of Psychiatry (T.M.S.), and Biostatistics Research Center (H.T.), Tufts Medical Center, Boston; Division of Nephrology (J.A.S.), St. Elizabeth's Medical Center, Brighton; and Division of Nephrology (A.K.S.), Brigham and Women's Hospital, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
David A. Drew, MD
From the Division of Nephrology (M.J.S., K.V.L., E.P.S., L.M.G., D.A.D., K.S., D.E.W.), Department of Medicine, Department of Psychiatry (T.M.S.), and Biostatistics Research Center (H.T.), Tufts Medical Center, Boston; Division of Nephrology (J.A.S.), St. Elizabeth's Medical Center, Brighton; and Division of Nephrology (A.K.S.), Brigham and Women's Hospital, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
American Society of Nephrology
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Kamran Shaffi, MD
From the Division of Nephrology (M.J.S., K.V.L., E.P.S., L.M.G., D.A.D., K.S., D.E.W.), Department of Medicine, Department of Psychiatry (T.M.S.), and Biostatistics Research Center (H.T.), Tufts Medical Center, Boston; Division of Nephrology (J.A.S.), St. Elizabeth's Medical Center, Brighton; and Division of Nephrology (A.K.S.), Brigham and Women's Hospital, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
James A. Strom, MD
From the Division of Nephrology (M.J.S., K.V.L., E.P.S., L.M.G., D.A.D., K.S., D.E.W.), Department of Medicine, Department of Psychiatry (T.M.S.), and Biostatistics Research Center (H.T.), Tufts Medical Center, Boston; Division of Nephrology (J.A.S.), St. Elizabeth's Medical Center, Brighton; and Division of Nephrology (A.K.S.), Brigham and Women's Hospital, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Ajay K. Singh, MD
From the Division of Nephrology (M.J.S., K.V.L., E.P.S., L.M.G., D.A.D., K.S., D.E.W.), Department of Medicine, Department of Psychiatry (T.M.S.), and Biostatistics Research Center (H.T.), Tufts Medical Center, Boston; Division of Nephrology (J.A.S.), St. Elizabeth's Medical Center, Brighton; and Division of Nephrology (A.K.S.), Brigham and Women's Hospital, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
US Department of the Army, Member of DSMB
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
Editor, Biosimilars
Patents:
1.
NONE
Publishing Royalties:
1.
Springer, Core Concepts Renal Transplantation 2011
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Sandoz, Member of Steering Committee Rockwell, PI of study
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Janssen Cilag, GRID Study
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
Expert witness, 2011, US Attorney's Office, acting for the defense
Daniel E. Weiner, MD, MS
From the Division of Nephrology (M.J.S., K.V.L., E.P.S., L.M.G., D.A.D., K.S., D.E.W.), Department of Medicine, Department of Psychiatry (T.M.S.), and Biostatistics Research Center (H.T.), Tufts Medical Center, Boston; Division of Nephrology (J.A.S.), St. Elizabeth's Medical Center, Brighton; and Division of Nephrology (A.K.S.), Brigham and Women's Hospital, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
Served on a scientific advisory board in March 2011 for Takeda Biopharmaceuticals.
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
Deputy Editor, American Journal of Kidney Diseases
Patents:
1.
NONE
Publishing Royalties:
1.
Editor of the Primer on Kidney Diseases, 6th Edition. Potential to receive royalties.
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Research funding, Keryx (Site PI) Research funding, Dialysis Clinic, Inc. (Investigator Initiated) Research funding, Covidien (Co-Investigator, Boston Site)
Research Support, Government Entities:
1.
NIDDK R01 DK090401(Co-PI), 09/20/2011-08/31/2015; Exercise Training and Cognitive and Physical Function in CKD NIH 268200900047C-0-0-1 (Role: Site PI); 11/01/2009-10/30/2018; The Systolic Blood Pressure Intervention Trial (SPRINT) NIK/NHLBI R01 HL107241 (Role: Site PI) 09/01/2011-06/30/2012; Pulse Wave Velocity and Central Aortic Pressure Outcomes in SPRINT NIH/NIDDK K23 DK071636 Role: PI; 09/30/2005-06/30/2011; Kidney Disease, Stroke and Cognitive Impairment
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
Carl W Gottschalk Research Scholar Grant; (PI: Weiner); 10/01/2010-09/30/2012; American Society of Nephrology; Medical, Economic and Ecologic Effects of Dialyzer Reprocessing Paul Teschan Research & Development Fund (Role: PI); 12/01/2009-11/30/2011; Administered by Dialysis Clinic, Inc; Transglutaminase 2 and Vascular Calcification in Chronic Kidney Disease: A Pilot Study
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence to Dr. Sarnak: [email protected]
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
The results presented in this article have not been published previously in whole or part, except in abstract format. An abstract based on the content of this manuscript was accepted as a poster at the American Society of Nephrology Annual Meeting in Philadelphia in 2011.

Author Contributions

Mark Sarnak: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, acquisition of data, study supervision, obtaining funding. Hocine Tighiouart: drafting/revising the manuscript, analysis or interpretation of data, statistical analysis. Tammy Scott: drafting/revising the manuscript, study concept or design, analysis or interpretation of data. Kristina Lou, Eric Sorensen, and Lena Giang: drafting/revising the manuscript, acquisition of data, study supervision. David Drew: drafting/revising the manuscript. Kamran Shaffi: drafting/revising the manuscript, study supervision. James Strom: drafting/revising the manuscript, analysis or interpretation of data, study supervision. Ajay Singh: drafting/revising the manuscript, contribution of vital reagents/tools/patients, study supervision. Daniel Weiner: drafting/revising the manuscript, study concept or design, analysis or interpretation of data, acquisition of data, statistical analysis, study supervision.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Cognitive and depressive disorders in older hypertensive patients, Ageing & Longevity, 3 2024, (97-104), (2024).https://doi.org/10.47855/jal9020-2024-3-1
    Crossref
  2. Unraveling of Molecular Mechanisms of Cognitive Frailty in Chronic Kidney Disease: How Exercise Makes a Difference, Journal of Clinical Medicine, 13, 19, (5698), (2024).https://doi.org/10.3390/jcm13195698
    Crossref
  3. MRC avanzata e genere: una visione pluriprospettica /multidimensionale, Giornale di Clinica Nefrologica e Dialisi, 36, 1, (10-17), (2024).https://doi.org/10.33393/gcnd.2024.3026
    Crossref
  4. Prevalence of Cognitive Impairment in Dialysis Patients in Gauteng Province, South Africa, Journal of Clinical Nephrology, 8, 2, (103-113), (2024).https://doi.org/10.29328/journal.jcn.1001136
    Crossref
  5. Subclinical cognitive impairment in chronic pancreatitis is associated with reduced mobility and quality of life, Clinical and Translational Gastroenterology, (2024).https://doi.org/10.14309/ctg.0000000000000685
    Crossref
  6. Prevalence of cognitive impairment and its predictors among chronic kidney disease patients: A systematic review and meta-analysis, PLOS ONE, 19, 6, (e0304762), (2024).https://doi.org/10.1371/journal.pone.0304762
    Crossref
  7. Chronic kidney disease and cognitive performance: NHANES 2011–2014, BMC Geriatrics, 24, 1, (2024).https://doi.org/10.1186/s12877-024-04917-2
    Crossref
  8. Research Progress on Cognitive Frailty in Older Adults with Chronic Kidney Disease, Kidney and Blood Pressure Research, (1-1), (2024).https://doi.org/10.1159/000538689
    Crossref
  9. Endothelium‐related biomarkers and cognitive decline in prevalent hemodialysis patients: A prospective cohort study, European Journal of Neurology, (2024).https://doi.org/10.1111/ene.16438
    Crossref
  10. The Clock Drawing Task reveals executive dysfunction in the dialysis population – an underrecognized and underestimated problem, Renal Failure, 46, 1, (2024).https://doi.org/10.1080/0886022X.2024.2306232
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share